News in tagged with „Global crowdsourcing“

BioMed X and Boehringer Ingelheim launch new crowdsourcing project to identify key regulatory mechanisms in innate immunity

Heidelberg, Germany, February 6th, 2017 – BioMed X announces the launch of a new global call in the fields of microbiology and immunology. Talented young scientists from the world’s top universities and research institutions are …

February 6, 2017 @ 10:09

BioMed X and Merck start new project in cancer research

Heidelberg, Germany, November 3rd, 2016 – BioMed X and Merck announce the start of a new research group at the BioMed X Innovation Center in Heidelberg. The new project entitled “DNA Damage in Cancer” represents …

November 3, 2016 @ 10:29

BioMed X announces the start of new research team on Oral Biofilm Disruption through continued collaboration with Johnson & Johnson Innovation

BioMed X Innovation Center announced today the official start of a new research group established through joint crowdsourcing efforts with Johnson & Johnson Consumer Inc. as a continuum of their original collaboration facilitated by Johnson …

September 6, 2016 @ 09:47

Boehringer Ingelheim and BioMed X start new project to explore and develop unprecedented new treatment approaches for psychiatric diseases applying crowdsourcing

Aims to identify maladaptive brain circuits to find new approaches for treating psychiatric diseases
Second Boehringer Ingelheim crowdsourcing project with BioMed X builds on success of previous project focused on epigenetic drivers of COPD

May 23, 2016 @ 10:00

BioMed X and Merck extend collaboration in cancer research

BioMed X and Merck KGaA announced today that they extend their current collaboration in the field of cancer research. The fourth joint research group of the BioMed X Innovation Center in Heidelberg, Germany, will focus …

March 3, 2016 @ 09:00

BioMed X – Merck collaboration in the field of selective kinase inhibitors reaches major milestone

BioMed X Innovation Center and Merck announced today that their collaboration, under which Merck has acquired all generated research and development results in the field of selective kinase inhibitors from BioMed X, has reached a …

January 13, 2016 @ 09:00